（旧版）「喘息ガイドライン作成に関する研究」平成11年度研究報告書/ガイドライン引用文献(2000年まで)簡易版抄録を掲載

参考文献

6-4-2-1.副腎皮質ステロイド薬

1. Gordon D, Raphael MD, Robert Q, et al. A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma. J Allergy Clin Immunol 1999; 103; 796-803. (I-A)
2. Guideline for the diagnosis and management of asthma.NIH Publication 1997; No.97-4031. (I-A)
3. Svendsen UG, Frolund L, Madsen F, et al. A comparison of the effects of sodium cromoglycate and beclomethasone dipropionate on pulmonary function and bronchial hyperreactivity in subjects with asthma. J Allergy Clin Immunol 1987;80:68-74. (I-A)
4. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med 1999; 10;159(9):941-955. (I-A)

6-4-2-2.抗アレルギー薬

5. Gong H, Tashkin DP, Dauphinee B, et al. Effect of oral cetirizine, a selective H1 antagonists, on allergen-and exercise-induced bronchoconstriction in subjects with asthma. J Allergy Clin Immunol 1990;85:632-641. (I-A)
6. Simons FER, Simons KJ. The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med 1994 ; 330: 1663-1670. (III-B)
7. Nathan RA, Bernstein JA, Bielory L, et al. Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction. J Allergy Clin Immunol 1998; 102: 935-942. (I-A)
8. Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethason, and プラセボ for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999; 130: 487-495. (I-A)

6-4-2-3.テオフィリン薬

9. Jackson SH, Johnston A, Woollard R, et al. The relationship between theophylline clearance and age in adult life. Eur J Clin Pharmacol 1989;36:29-34. (II-2-A)
10. Samaan S, Fox R. The effect of smoking on theophylline kinetics in healthy and asthmatic elderly males. J Clin Pharmacol 1989;29: 448-450. (II-2-A)
11. Reed CE, Offord KP, Nelson HS, et al. Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group. J Allergy Clin Immunol 1998; 101:14-23. (I-A)
12. Galant SP, Lawrence M, Meltzer EO, et al. Fluticasone propionate compared with theophylline for mild-to-moderate asthma. Ann Allergy Asthma Immunol 1996;77:112-118. (I-A)

6-4-2-4.β₂刺激薬と抗コリン薬

13. Ullah MI, Newman GB, Saunders KB. Influence of age on response to ipratropium and salbutamol in asthma. Thorax 1981;36 : 523- 529. (I-B)
14. van Schayck CP, Folgering H, Harbers H, et al. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. Thorax 1991; 46: 355- 359. (I-B)
15. Stoodely RG, Aaron SD, Dales RE. The role of ipratropium in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Ann Emerg Med 1999;34 :8-18. (I-B)
16. Idris AH, Mc Dermott MF, Raucci JC, et al. Emergency department treatment of asthma: metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest 1993;103: 665-672. (I-B)
17. Martin RJ, Kraft M, Beaucher WN, et al. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma. Ann Allergy Asthma Immunol 1999;83: 121-126. (I-A)
18. Lim R, Walshaw MJ, Saltissis S, et al. Cardiac arrhythmias during acute exacerbations of chronic airflow limitation : effect of fall in plasma potassium concentration induced by nebulised beta 2-agonist therapy. Postgrad Med J 1989;65 : 449-452. (II-2-D)